Concepedia
Statistics
Publications
11
Citations
1.7K
H-Index
Active since
1999
Affiliations
National Cancer Institute(Current)
Center for Cancer Research
National Institutes of Health Clinical Center
Cardinal Glennon Children’s Medical Center
National Institutes of Health
Susan Bakke is an author at National Cancer Institute specializing in pharmacology, medicine, and chemotherapy.
Publications per year
1999–2011
Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms.
Victor Sandor, Susan Bakke, Robert W. Robey et al. · PubMed · 2002 · 510 citations
Medicine, Clinical Pharmacokinetics, Pharmacology +12
Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report
Richard Piekarz, Robert W. Robey, Victor Sandor et al. · Blood · 2001 · 447 citations · Full text
Medicine, Oncology, Pharmacology +11
Phase I Trial and Pharmacokinetic Study of BMS-247550, an Epothilone B Analog, Administered Intravenously on a Daily Schedule for Five Days
Jame Abraham, Manish Agrawal, Susan Bakke et al. · Journal of Clinical Oncology · 2003 · 136 citations
Medicine, Pharmacokinetics, Pharmacology +12
A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma
Jame Abraham, Susan Bakke, Ann Rutt et al. · Cancer · 2002 · 120 citations
Medicine, Oncology, Pharmacology +15
A Phase I Study of the P-Glycoprotein Antagonist Tariquidar in Combination with Vinorelbine
Jame Abraham, Maureen Edgerly, Richard H. Wilson et al. · Clinical Cancer Research · 2009 · 117 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +10
1–5 of 11